Early proteostasis of caveolins synchronizes trafficking, degradation, and oligomerization to prevent toxic aggregation.


Journal

The Journal of cell biology
ISSN: 1540-8140
Titre abrégé: J Cell Biol
Pays: United States
ID NLM: 0375356

Informations de publication

Date de publication:
04 09 2023
Historique:
received: 07 04 2022
revised: 05 04 2023
accepted: 09 06 2023
medline: 2 8 2023
pubmed: 1 8 2023
entrez: 1 8 2023
Statut: ppublish

Résumé

Caveolin-1 (CAV1) and CAV3 are membrane-sculpting proteins driving the formation of the plasma membrane (PM) caveolae. Within the PM mosaic environment, caveola assembly is unique as it requires progressive oligomerization of newly synthesized caveolins while trafficking through the biosynthetic-secretory pathway. Here, we have investigated these early events by combining structural, biochemical, and microscopy studies. We uncover striking trafficking differences between caveolins, with CAV1 rapidly exported to the Golgi and PM while CAV3 is initially retained in the endoplasmic reticulum and laterally moves into lipid droplets. The levels of caveolins in the endoplasmic reticulum are controlled by proteasomal degradation, and only monomeric/low oligomeric caveolins are exported into the cis-Golgi with higher-order oligomers assembling beyond this compartment. When any of those early proteostatic mechanisms are compromised, chemically or genetically, caveolins tend to accumulate along the secretory pathway forming non-functional aggregates, causing organelle damage and triggering cellular stress. Accordingly, we propose a model in which disrupted proteostasis of newly synthesized caveolins contributes to pathogenesis.

Identifiants

pubmed: 37526691
pii: 276141
doi: 10.1083/jcb.202204020
pmc: PMC10394380
pii:
doi:

Substances chimiques

Caveolins 0
Caveolin 1 0
Membrane Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023 Morales-Paytuví et al.

Références

Skelet Muscle. 2018 Aug 28;8(1):28
pubmed: 30153853
FEBS Lett. 1996 Jun 17;388(2-3):143-9
pubmed: 8690074
Hum Mol Genet. 2014 Jan 1;23(1):129-44
pubmed: 24021477
Traffic. 2010 Mar;11(3):361-82
pubmed: 20070607
J Biol Chem. 2000 Dec 1;275(48):37702-11
pubmed: 10973975
Cancer Res. 2001 Mar 15;61(6):2361-4
pubmed: 11289096
Annu Rev Cell Dev Biol. 2018 Oct 6;34:111-136
pubmed: 30296391
Nucleic Acids Res. 1988 Nov 25;16(22):10881-90
pubmed: 2849754
J Biol Chem. 2013 Mar 8;288(10):7363-72
pubmed: 23335559
Am J Physiol Cell Physiol. 2003 Nov;285(5):C1150-60
pubmed: 12839838
Elife. 2017 Jun 08;6:
pubmed: 28594326
Bioinformatics. 2008 Sep 15;24(18):2101-2
pubmed: 18662927
Traffic. 2016 Dec;17(12):1297-1312
pubmed: 27717241
Proc Natl Acad Sci U S A. 2003 May 27;100(11):6511-6
pubmed: 12743374
Bioinformatics. 2019 Aug 15;35(16):2856-2858
pubmed: 30615063
J Cell Biol. 1994 Dec;127(5):1233-43
pubmed: 7962086
Cancer Metastasis Rev. 2020 Jun;39(2):397-414
pubmed: 32279119
Molecules. 2021 Oct 14;26(20):
pubmed: 34684779
Nat Cell Biol. 2011 Aug 07;13(9):1116-23
pubmed: 21822278
Mol Biol Cell. 2005 Apr;16(4):2091-105
pubmed: 15689493
J Cell Biol. 1995 Dec;131(6 Pt 1):1421-33
pubmed: 8522601
Oxid Med Cell Longev. 2020 Jan 27;2020:9761539
pubmed: 32082483
Traffic. 2006 Sep;7(9):1254-69
pubmed: 17004324
Nat Methods. 2022 Jun;19(6):679-682
pubmed: 35637307
Nat Cell Biol. 2023 Jan;25(1):120-133
pubmed: 36543981
Cell Signal. 2018 Jul;47:65-78
pubmed: 29596872
J Cell Sci. 2008 Jun 15;121(Pt 12):2075-86
pubmed: 18505796
Nature. 2015 Oct 22;526(7574):564-8
pubmed: 26444236
Traffic. 2013 Jun;14(6):663-77
pubmed: 23469926
Dev Cell. 2018 Jan 8;44(1):97-112.e7
pubmed: 29275994
J Cell Biol. 2010 Nov 1;191(3):615-29
pubmed: 21041450
Front Cell Dev Biol. 2016 Jun 27;4:68
pubmed: 27446919
Mol Biol Cell. 2017 Nov 1;28(22):3095-3111
pubmed: 28904206
Cell. 2012 Aug 17;150(4):752-63
pubmed: 22901807
J Biol Chem. 1996 Jun 21;271(25):15160-5
pubmed: 8663016
J Cell Biol. 2001 Mar 5;152(5):1071-8
pubmed: 11238461
Semin Cell Dev Biol. 2020 Dec;108:33-46
pubmed: 32146030
J Cell Sci. 2007 Jul 1;120(Pt 13):2151-61
pubmed: 17550965
Nature. 2021 Aug;596(7873):583-589
pubmed: 34265844
Front Cell Dev Biol. 2023 Jan 26;11:1113656
pubmed: 36776558
Nat Cell Biol. 1999 Jun;1(2):98-105
pubmed: 10559881
Nat Rev Mol Cell Biol. 2019 Jul;20(7):421-435
pubmed: 30733602
Mol Biol Cell. 1995 Jul;6(7):911-27
pubmed: 7579702
Science. 2016 Jul 1;353(6294):aac4354
pubmed: 27365453
Am J Pathol. 2002 Oct;161(4):1357-69
pubmed: 12368209
Eur J Biochem. 2004 May;271(10):2028-36
pubmed: 15128312
EMBO Rep. 2018 Aug;19(8):
pubmed: 29945933
Sci Rep. 2019 Feb 13;9(1):1969
pubmed: 30760735
J Cell Biol. 2001 Mar 5;152(5):1057-70
pubmed: 11238460
J Biol Chem. 1999 Aug 6;274(32):22660-7
pubmed: 10428847
J Biol Chem. 2023 Apr;299(4):104574
pubmed: 36870682
Nat Genet. 1998 Apr;18(4):365-8
pubmed: 9537420
J Cell Biol. 1999 Jun 28;145(7):1443-59
pubmed: 10385524
Traffic. 2020 Jan;21(1):181-185
pubmed: 31448516
J Cell Sci. 2015 Apr 1;128(7):1269-78
pubmed: 25829513
Trends Cell Biol. 2016 Mar;26(3):177-189
pubmed: 26653791
Sci Rep. 2019 Jul 8;9(1):9888
pubmed: 31285524
Ageing Res Rev. 2020 Sep;62:101116
pubmed: 32554058
J Microsc. 2006 Dec;224(Pt 3):213-32
pubmed: 17210054
J Lipid Res. 1998 Feb;39(2):369-79
pubmed: 9507997
J Biol Chem. 1999 Sep 3;274(36):25718-25
pubmed: 10464309
J Biol Chem. 2004 Aug 27;279(35):36828-40
pubmed: 15199055
J Cell Biol. 2005 Aug 29;170(5):769-79
pubmed: 16129785
Sci Adv. 2022 May 13;8(19):eabq6985
pubmed: 35544565
Hum Mol Genet. 2011 Aug 1;20(15):2975-83
pubmed: 21610159
J Cell Sci. 2020 May 11;133(9):
pubmed: 32393675
Nature. 1997 Jun 5;387(6633):569-72
pubmed: 9177342
Sci Adv. 2022 May 13;8(19):eabn7232
pubmed: 35544577
J Biol Chem. 1999 Sep 3;274(36):25632-41
pubmed: 10464299
Nucleic Acids Res. 2014 Jul;42(Web Server issue):W320-4
pubmed: 24753421
Science. 2020 Oct 16;370(6514):
pubmed: 33060333

Auteurs

Frederic Morales-Paytuví (F)

Lipid Trafficking and Disease Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

Alba Fajardo (A)

Lipid Trafficking and Disease Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

Carles Ruiz-Mirapeix (C)

Lipid Trafficking and Disease Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

James Rae (J)

Institute for Molecular Bioscience (IMB), The University of Queensland (UQ) , Brisbane, Australia.

Francesc Tebar (F)

Department of Biomedical Sciences, Faculty of Medicine, Universitat de Barcelona, Barcelona, Spain.

Marta Bosch (M)

Lipid Trafficking and Disease Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Department of Biomedical Sciences, Faculty of Medicine, Universitat de Barcelona, Barcelona, Spain.

Carlos Enrich (C)

Department of Biomedical Sciences, Faculty of Medicine, Universitat de Barcelona, Barcelona, Spain.

Brett M Collins (BM)

Institute for Molecular Bioscience (IMB), The University of Queensland (UQ) , Brisbane, Australia.

Robert G Parton (RG)

Institute for Molecular Bioscience (IMB), The University of Queensland (UQ) , Brisbane, Australia.
Centre for Microscopy and Microanalysis (CMM), The University of Queensland (UQ), Brisbane, Australia.

Albert Pol (A)

Lipid Trafficking and Disease Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Department of Biomedical Sciences, Faculty of Medicine, Universitat de Barcelona, Barcelona, Spain.
Institució Catalana de Recerca i Estudis Avançats (ICREA) , Barcelona, Spain.

Articles similaires

Humans Animals Adherens Junctions Intercellular Junctions Tight Junctions
1.00
Plasmodesmata Endoplasmic Reticulum Arabidopsis Cytokinesis Arabidopsis Proteins
Humans Stomach Neoplasms Macrophages Tumor Microenvironment Disease Progression
Animals Humans TOR Serine-Threonine Kinases Lupus Erythematosus, Systemic Arthritis, Rheumatoid

Classifications MeSH